Senior management changes at Merck & Co
This article was originally published in Scrip
Merck & Co has announced changes to its senior management team: president of the global human health worldwide sales and marketing division Kenneth Frazier has been elected as company president, effective 1 May. He will report to the Merck's current chairman, CEO and president, Richard Clark, who will continue to lead the company as chairman and CEO. Adam Schechter, president of the company's pharmaceutical business in the US, has been elected to succeed Mr Frazier as president of global human health.